These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9811500)

  • 21. Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice.
    Mohanan D; Gander B; Kündig TM; Johansen P
    Eur J Pharm Biopharm; 2012 Feb; 80(2):274-81. PubMed ID: 22024408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
    Benny O; Duvshani-Eshet M; Cargioli T; Bello L; Bikfalvi A; Carroll RS; Machluf M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):768-76. PubMed ID: 15701867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of encapsulated single chain antibodies for induction of anti-idiotypic humoral and cellular immune responses.
    Ma J; Luo D; Kwon GS; Samuel J; Noujaim AA; Madiyalakan R
    J Pharm Sci; 1998 Nov; 87(11):1375-8. PubMed ID: 9811493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus E2 protein encapsulation into poly d, l-lactic-
    Roopngam P; Liu K; Mei L; Zheng Y; Zhu X; Tsai HI; Huang L
    Int J Nanomedicine; 2016; 11():5361-5370. PubMed ID: 27789948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres.
    Men Y; Gander B; Merkle HP; Corradin G
    Vaccine; 1996 Oct; 14(15):1442-50. PubMed ID: 8994320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
    Hamdy S; Elamanchili P; Alshamsan A; Molavi O; Satou T; Samuel J
    J Biomed Mater Res A; 2007 Jun; 81(3):652-62. PubMed ID: 17187395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo.
    Newman KD; Elamanchili P; Kwon GS; Samuel J
    J Biomed Mater Res; 2002 Jun; 60(3):480-6. PubMed ID: 11920673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
    Jiang W; Gupta RK; Deshpande MC; Schwendeman SP
    Adv Drug Deliv Rev; 2005 Jan; 57(3):391-410. PubMed ID: 15560948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.
    Pavot V; Berthet M; Rességuier J; Legaz S; Handké N; Gilbert SC; Paul S; Verrier B
    Nanomedicine (Lond); 2014 Dec; 9(17):2703-18. PubMed ID: 25529572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue.
    Gad M; Jensen T; Gagne R; Komba S; Daugaard S; Kroman N; Meldal M; Werdelin O
    Eur J Immunol; 2003 Jun; 33(6):1624-32. PubMed ID: 12778480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodegradable microspheres containing influenza A vaccine: immune response in mice.
    Hilbert AK; Fritzsche U; Kissel T
    Vaccine; 1999 Mar; 17(9-10):1065-73. PubMed ID: 10195616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1.
    Pisarev VM; Kinarsky L; Caffrey T; Hanisch FG; Sanderson S; Hollingsworth MA; Sherman S
    Int Immunopharmacol; 2005 Feb; 5(2):315-30. PubMed ID: 15652762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PLGA-Listeriolysin O microspheres: Opening the gate for cytosolic delivery of cancer antigens.
    Gilert A; Baruch L; Bronshtein T; Machluf M
    Biomed Microdevices; 2016 Apr; 18(2):23. PubMed ID: 26888439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens.
    Apostolopoulos V; Xing PX; McKenzie IF
    Cancer Res; 1994 Oct; 54(19):5186-93. PubMed ID: 7923138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desensitizing mice to ovalbumin through subcutaneous microsphere immunotherapy (SMITH).
    Reisacher WR; Liotta D; Yazdi S; Putnam D
    Int Forum Allergy Rhinol; 2011; 1(5):390-5. PubMed ID: 22287471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
    Jaganathan KS; Vyas SP
    Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and evaluation of surface and adjuvant modified PLGA microspheres for uptake by dendritic cells to improve vaccine responses.
    Salvador A; Sandgren KJ; Liang F; Thompson EA; Koup RA; Pedraz JL; Hernandez RM; Loré K; Igartua M
    Int J Pharm; 2015 Dec; 496(2):371-81. PubMed ID: 26475970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
    Saini V; Jain V; Sudheesh MS; Jaganathan KS; Murthy PK; Kohli DV
    Int J Pharm; 2011 Apr; 408(1-2):50-7. PubMed ID: 21291968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.